The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Aug 31, 2026
Snapshot (as of Aug 31, 2026): Quest Diagnostics Incorporated (DGX) pays a $3.32 annual dividend ($0.86 quarterly), yielding 1.37% at $242.76/share. Next ex-dividend date 2026-10-06. 20+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.37%
Annual Dividend: $3.32 per share
Payout Ratio: 34.2%
Ex-Dividend Date: 2026-10-06
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 23
Quest Diagnostics Incorporated dividend investors get a business built on diagnostic testing demand: the company runs one of the largest networks of laboratories and patient service centers in the U.S., serving clinicians, hospitals, and health plans under brands including Quest Diagnostics, AmeriPath, and ExamOne. The current yield is 1.42%, with a trailing annual dividend rate of $3.32 per share paid quarterly. The next ex-dividend date is October 6, 2026. A beta of 0.548 means DGX stock moves at roughly half the volatility of the broader market, which suits investors who prioritize income steadiness over price swings.
Quest Diagnostics Incorporated pays out 34.2% of earnings as dividends, a payout ratio classified as conservative (below 40%). That leaves a wide buffer between earnings and the dividend, and the company's core business of routine and advanced clinical testing serves a broad, recurring client base of clinicians, hospitals, and health plans. Quest Diagnostics Incorporated dividend safety benefits from that demand profile, though any material shift in reimbursement rates or testing volumes could pressure earnings and, by extension, the payout.
Quest Diagnostics Incorporated dividend history shows a CAGR of 15.9% per year from 2011 to 2025. The per-share dividend grew from $0.40 to $3.15 over that window (2026 data is partial and excluded from the CAGR calculation). The smallest annual increase in the window was 4.2% in 2020, which still represents uninterrupted forward movement even in a difficult year for healthcare operations.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +6.6% | $2.60 (2022) | $3.15 (2025) |
| 5-Year | +7.3% | $2.21 (2020) | $3.15 (2025) |
| 10-Year | +7.9% | $1.47 (2015) | $3.15 (2025) |
DGX fits growth-and-income investors who want dividend expansion rather than a high starting yield. The current yield of 1.42% is low (below 2%), and it sits above the 5-year average of 1.19%, so the stock is actually offering more income relative to price than it has historically. Twenty consecutive years of dividend increases and a 15.9% CAGR are the real draw here. The trade-off is straightforward: investors accept a modest current income stream in exchange for a dividend that has compounded at a fast pace over time. The 34.2% payout ratio means there is room to keep that growth going, but the yield itself will not satisfy investors who need immediate, high income.
| Payment Date | Amount per Share |
|---|---|
| 2026-10-06 | $0.8600 |
| 2026-07-08 | $0.8600 |
| 2026-04-06 | $0.8600 |
| 2026-01-13 | $0.8000 |
| 2025-10-03 | $0.8000 |
| 2025-07-07 | $0.8000 |
| 2025-04-07 | $0.8000 |
| 2025-01-14 | $0.7500 |
| 2024-10-04 | $0.7500 |
| 2024-07-08 | $0.7500 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.3800 |
| 2025 | $3.1500 |
| 2024 | $2.9600 |
| 2023 | $2.7900 |
| 2022 | $2.6000 |
Project income from DGX with the DGX dividend calculator or track your full portfolio with the dividend tracker.